Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Front Immunol ; 12: 595343, 2021.
Article in English | MEDLINE | ID: covidwho-1133908

ABSTRACT

Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin (SIgA). Therefore, in this study, we investigated the levels of specific-SIgA for SARS-CoV-2 and cytokines in the airways mucosa 37 patients who were suspected of COVID-19. According to the RT-PCR results, the patients were separated into three groups: negative for COVID-19 and other viruses (NEGS, n = 5); negative for COVID-19 but positive for the presence of other viruses (OTHERS, n = 5); and the positive for COVID-19 (COVID-19, n = 27). Higher specific-SIgA for SARS-CoV-2, IFN-ß, and IFN-γ were found in the COVID-19 group than in the other groups. Increased IL-12p70 levels were observed in OTHERS group as compared to COVID-19 group. When the COVID-19 group was sub stratified according to the illness severity, significant differences and correlations were found for the same parameters described above comparing severe COVID-19 to the mild COVID-19 group and other non-COVID-19 groups. For the first time, significant differences are shown in the airway's mucosa immune responses in different groups of patients with or without respiratory SARS-CoV-2 infection.


Subject(s)
Antibodies, Viral/metabolism , COVID-19/immunology , Immunoglobulin A/metabolism , Interferons/metabolism , Lung/pathology , Nasal Mucosa/metabolism , SARS-CoV-2/physiology , Adolescent , Adult , Aged , Brazil , Child , Disease Progression , Female , Humans , Male , Middle Aged , Nasal Mucosa/immunology , Young Adult
2.
Eur J Clin Invest ; 51(5): e13485, 2021 May.
Article in English | MEDLINE | ID: covidwho-1003974

ABSTRACT

The new coronavirus (SARS-CoV-2) appearance in Wuhan, China, did rise the new virus disease (COVID-19), which spread globally in a short time, leading the World Health Organization to declare a new global pandemic. To contain and mitigate the spread of SARS-CoV-2, specific public health procedures were implemented in virtually all countries, with a significant impact on society, making it difficult to keep the regular practice of physical activity. It is widely accepted that an active lifestyle contributes to the improvement of general health and preservation of cardiovascular, respiratory, osteo-muscular and immune system capacities. The positive effects of regular physical activity on the immune system have emerged as a pivotal trigger of general health, underlying the beneficial effects of physical activity on multiple physiological systems. Accordingly, recent studies have already pointed out the negative impact of physical inactivity caused by the social isolation imposed by the public sanitary authorities due to COVID-19. Nevertheless, there are still no current narrative reviews evaluating the real impact of COVID-19 on active lifestyle or even discussing the possible beneficial effects of exercise-promoted immune upgrade against the severity or progression of COVID-19. Based on the consensus in the scientific literature, in this review, we discuss how an exercise adherence could adequately improve immune responses in times of the 'COVID-19 Era and beyond'.


Subject(s)
COVID-19 , Exercise/physiology , Immunity/immunology , Inflammation/immunology , Leukocytes/immunology , Communicable Disease Control , Cytokines/immunology , Gonadal Steroid Hormones/immunology , Humans , Hydrocortisone/immunology , Killer Cells, Natural/immunology , Neutrophils/immunology , Patient Compliance , Phagocytosis/immunology , Public Policy , SARS-CoV-2 , Sedentary Behavior , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL